Yiheng Capital
Multi-Strategy- Manager
- Yiheng Capital
- Quarter
- Q2 2026
- Filed
- 2026-08-14
- 13F value
- $234.6M
- Positions
- 25
- CIK
- 0001447228
| # | # Shares | Source | ||||||
|---|---|---|---|---|---|---|---|---|
| 1 | Noah Hldgs LTDNOAHHISTORY | 28.61% | — | $67.1M | 6,717,351 | — | 2.00% | 13F |
| 2 | Bilibili IncBILIHISTORY | 10.82% | +101.3% | $25.4M | 1,489,815 | +749,900 | 0.46% | 13F |
| 3 | Jd.com IncJDHISTORY | 6.41% | +0.5% | $15.0M | 590,513 | +3,000 | 0.02% | 13F |
| 4 | H World Group LTDHTHTHISTORY | 5.75% | — | $13.5M | 323,371 | — | 0.01% | 13F |
| 5 | Hinge Health IncHNGEHISTORY | 5.53% | (47.4%) | $13.0M | 156,190 | (140,663) | 0.20% | 13F |
| 6 | Silvaco Group IncSVCOHISTORY | 5.33% | (17.3%) | $12.5M | 906,381 | (189,901) | 2.67% | 13F |
| 7 | Atrenew IncREREHISTORY | 5.22% | — | $12.2M | 3,163,117 | — | 1.96% | 13F |
| 8 | Bill Holdings IncBILLHISTORY | 3.44% | — | $8.1M | 222,820 | — | 0.26% | 13F |
| 9 | New Oriental Ed & TechnologyEDUHISTORY | 3.20% | (99.6%) | $7.5M | 1,636 | (374,915) | 0.00% | 13F |
| 10 | Viridian Therapeutics IncVRDNHISTORY | 3.14% | +91.9% | $7.4M | 400,464 | +191,729 | 0.35% | 13F |
| 11 | Kymera Therapeutics IncKYMRHISTORY | 3.10% | (13.6%) | $7.3M | 63,440 | (10,000) | 0.08% | 13F |
| 12 | Tal Ed GroupTALHISTORY | 3.10% | — | $7.3M | 759,240 | — | 0.40% | 13F |
| 13 | Joyy IncJOYYHISTORY | 2.41% | — | $5.6M | 85,583 | — | 0.01% | 13F |
| 14 | Power Solutions Intl IncPSIXHISTORY | 2.21% | NEW | $5.2M | 133,500 | +133,500 | 0.58% | 13F |
| 15 | Pony Ai IncPONYHISTORY | 1.94% | — | $4.5M | 653,215 | — | 0.15% | 13F |
| 16 | Bioage Labs IncBIOAHISTORY | 1.78% | NEW | $4.2M | 170,532 | +170,532 | 0.37% | 13F |
| 17 | Full Truck Alliance Co LTDYMMHISTORY | 1.78% | — | $4.2M | 513,248 | — | 0.00% | 13F |
| 18 | Trip Com Group LTDTCOMHISTORY | 1.50% | — | $3.5M | 88,112 | — | 0.01% | 13F |
| 19 | Yatsen Hldg LTDYSGHISTORY | 1.28% | +18.6% | $3.0M | 946,193 | +148,327 | 0.05% | 13F |
| 20 | Agora IncAPIHISTORY | 1.23% | — | $2.9M | 725,795 | — | 0.20% | 13F |
| 21 | DBV Technologies S ADBVTHISTORY | 1.19% | — | $2.8M | 170,142 | — | 0.06% | 13F |
| 22 | Zepp Health CorporationZEPPHISTORY | 0.49% | +281.9% | $1.1M | 220,501 | +162,770 | 0.09% | 13F |
| 23 | Beam Therapeutics IncBEAMHISTORY | 0.31% | — | $0.7M | 21,126 | — | 0.02% | 13F |
| 24 | Passage Bio IncPASGHISTORY | 0.18% | — | $0.4M | 86,097 | — | 2.68% | 13F |
| 25 | Tuniu CorpTOURHISTORY | 0.06% | NEW | $0.2M | 31,443 | +31,443 | 0.01% | 13F |
Positions are from the latest 13F-HR (period end 2026-06-30). Weights are calculated: position value ÷ the 13F book. Schedule 13D/13G stakes are merged in when present (shares and percent of class, no dollar value). Chg Shares and % Chg compare with the adjacent prior quarter's 13F only. % Out is either calculated (position shares ÷ issuer shares outstanding from the issuer's XBRL cover page; weighted-average basic shares as a fallback) or reported (percent of class on a Schedule 13D/13G newer than the 13F period) — hover a value for its source and date. Unavailable figures show “—”, never an estimate. Methodology